Latest Operational Efficiency News

Tamawood Limited has reported a steady increase in revenue and profit for the half year ended December 31, 2024, signaling ongoing resilience in the residential construction sector.

Kinetiko Energy reports sustained and improving gas flows from its South African test wells, prompting a drilling optimization study to enhance recovery and support future production.

Belararox Limited has initiated drilling at its Malambo copper-gold porphyry target and is making steady progress at Tambo South, marking a pivotal phase in the Toro-Malambo-Tambo Project in Argentina.

Challenger Gold has reached a key milestone in its Hualilan project, finalising mine designs and schedules that increase mineral grades by 10%, while progressing toll milling readiness and operational flexibility.

ABx Group and Core Refining have mutually terminated their licence agreement as ABx pivots to a more cost-effective and sustainable method for producing aluminium fluoride, advancing the ALCORE project into its continuous pilot phase in Tasmania.

Alcidion has secured its first contract in Wales with Hywel Dda University Health Board, deploying its Miya Precision Platform to enhance patient flow and clinical communication over five years.

Burgundy Diamond Mines showcased its vertically integrated diamond business and Ekati mine acquisition at the Bell Potter Unearthed Natural Resources Conference, outlining a robust 2025 operational and financial outlook despite market headwinds.

Breville Group Limited reported a robust half-year performance with 10.1% revenue growth and a 16.1% rise in net profit, driven by strong coffee category sales and strategic product launches. Despite macroeconomic headwinds and tariff concerns, the company maintains a confident outlook for FY25.

Breville Group Limited reported a robust half-year performance with a 10.1% rise in revenue to nearly A$1 billion and a 16.1% jump in net profit, underpinning confidence in its premium appliance strategy.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

CSL Limited posted a robust half-year performance with NPATA rising 5% at constant currency, driven by strong growth in CSL Behring and CSL Vifor despite challenges in its influenza vaccine segment. The company reaffirmed its FY25 guidance, anticipating double-digit earnings growth.

CSL Limited reported a solid 5% revenue increase and 6% rise in net profit after tax for the half year ended December 2024, underpinned by robust performance in its plasma therapies business despite headwinds in its influenza vaccine segment.